Patent expiry of key blockbuster drugs good news for generics manufacturers, says F&S

The global generic pharmaceuticals market is likely to witness strong growth in the next few years owing to the patent expiration of key blockbuster drugs and the judicious cost containment efforts of governments and health care service providers worldwide. At the same time, the balance in terms of health care expenditure and sales revenue is poised to shift from developed to emerging markets such as India, China, Brazil, Russia, Turkey and South Korea, as huge potential still remains untapped in these countries.